hiv-infections

Documents about hiv-infections

• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth#903226ClinicalTrials.gov
• Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis#836044ClinicalTrials.gov
• A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients#900913ClinicalTrials.gov
• Hypocoagulability among people living with HIV at Hoima Regional Referral Hospital, Western Uganda: a cross-sectional study.#9892PubMed
• Scaling-up highly active antiretroviral therapy (HAART) in Peru: Problems on the horizon [2]#277459Repositorio Universidad Peruana Cayetano Heredia
• HIV treatment and care: treat all: policy adoption and implementation status in countries#381549WHO IRIS
• An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe.#431475PubMed
• Pain and substance use among persons living with HIV: associations with co-morbid illness and viral suppression.#477158PubMed
• A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection#806987ClinicalTrials.gov
• Peer Groups for Healthy Pregnancy & HIV Prevention for Young Malawian Women#830734ClinicalTrials.gov
• Improving Latent Tuberculosis (TB) Diagnosis in Thai Children#853804ClinicalTrials.gov
• Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)#861797ClinicalTrials.gov
• Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)#876356ClinicalTrials.gov
• Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants#878734ClinicalTrials.gov
• Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz#880233ClinicalTrials.gov
• The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)#886798ClinicalTrials.gov
• GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers#906304ClinicalTrials.gov
• Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1#906818ClinicalTrials.gov
• Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome#894729ClinicalTrials.gov
• The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs#810911ClinicalTrials.gov
• Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients#846251ClinicalTrials.gov
• Guidelines for HIV diagnosis and monitoring of antiretroviral therapy#627348WHO IRIS
• Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women#803842ClinicalTrials.gov
• Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)#827225ClinicalTrials.gov
• A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3#811169ClinicalTrials.gov
• A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa#143651ClinicalTrials.gov
• Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)#160411ClinicalTrials.gov
• Examining the Effects of Theory-based Education on Individuals' Sexual Behavior.#906143ClinicalTrials.gov
• A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients#910230ClinicalTrials.gov
• A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible#839368ClinicalTrials.gov
• The impact of cytokine levels in young South African children with and without HIV-associated acute lower respiratory infections#385879University of Pretoria Repository
• Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)#226315ClinicalTrials.gov
• Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC#807755ClinicalTrials.gov
• Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa#844712ClinicalTrials.gov
• Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)#845395ClinicalTrials.gov
• A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59#28426ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults#121459ClinicalTrials.gov
• Policy brief: HIV prevention, diagnosis, treatment and care for key populations: consolidated guidelines July 2014#373058WHO IRIS
• Exploratory assessment of nutrient-related food-frequency proxy measures among people with HIV by secondary chronic condition status.#786156PubMed
• A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients#801198ClinicalTrials.gov
• Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients#837841ClinicalTrials.gov
• Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects#843886ClinicalTrials.gov
• A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection#849004ClinicalTrials.gov
• Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care#869186ClinicalTrials.gov
• Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®#877539ClinicalTrials.gov
• Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses#896506ClinicalTrials.gov
• Safety, Tolerability, and Efficacy of a Dose Reduction Strategy Based on Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-infected Adults#903634ClinicalTrials.gov
• An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen#843766ClinicalTrials.gov
• Risk Taking Behaviour in MSM and the Denial of Sexually Transmitted Diseases and HIV#870804ClinicalTrials.gov
• A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.#830998ClinicalTrials.gov